Press release
Glucagon Market Set to Witness Significant Growth by 2032 | Eli Lilly and Company, Novo Nordisk, Amphastar Pharmaceuticals, Xeris Pharmaceuticals
In 2023, the global glucagon market was valued at approximately USD 422.6 million. Projections indicate that the market will reach around USD 742.3 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.9% from 2024 to 2032.Request a sample copy of this report at: https://www.omrglobal.com/request-sample/glucagon-market
Glucagon Market Overview:
The global glucagon market is experiencing steady growth, driven by its critical role in managing severe hypoglycemia, particularly among individuals with diabetes. In 2023, the market was valued at approximately USD 621.3 million and is projected to reach around USD 1,102 million by 2033, reflecting a compound annual growth rate (CAGR) of 5.9% during the forecast period. This expansion is attributed to the increasing prevalence of diabetes worldwide and the essential need for effective emergency treatments to address acute hypoglycemic episodes.
Glucagon Market Growth Factors:
Several factors contribute to the growth of the glucagon market. The rising incidence of diabetes has led to a higher number of patients at risk for hypoglycemia, thereby increasing the demand for glucagon as a critical emergency intervention. Advancements in pharmaceutical research have resulted in the development of more user-friendly glucagon delivery devices, enhancing patient compliance and expanding the market. Furthermore, growing awareness among healthcare professionals and patients about the importance of managing hypoglycemia effectively has bolstered the adoption of glucagon therapies.
◘ The report further explores the key business players along with their in-depth profiling
Eli Lilly and Company, Novo Nordisk, Amphastar Pharmaceuticals, Xeris Pharmaceuticals, Zealand Pharma, Fresenius Kabi, Torrent Pharmaceuticals, Taj Pharmaceuticals, Sichuan Deebio Pharmaceutical, and Hanmi Pharmaceutical.
Glucagon Market Segments:
◘ By Type: Injectable, Nasal, Auto-Injectors
◘ By Application: Diabetes, Hypoglycemia, Hospitals
Glucagon Market Drivers & Trends Analysis:
Key drivers in the glucagon market include the continuous innovation in delivery mechanisms, such as the introduction of nasal glucagon and auto-injectors, which offer ease of use and improved patient adherence. The increasing emphasis on patient education regarding diabetes management has also played a significant role in promoting the use of glucagon. Additionally, strategic collaborations and partnerships among pharmaceutical companies are fostering the development and commercialization of novel glucagon formulations. A notable trend is the shift towards non-injectable emergency glucagon options, reflecting patient preference for less invasive administration methods.
If you have any special requirements, Request customization: https://www.omrglobal.com/report-customization/glucagon-market
Regional Outlook:
The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.
» North America (U.S., Canada, Mexico)
» Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
» Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
» South America (Brazil, Argentina, Rest of SA)
» Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Key Benefits for Stakeholders:
⏩ The study represents a quantitative analysis of the present Glucagon Market trends, estimations, and dynamics of the market size from 2025 to 2032 to determine the most promising opportunities.
⏩ Porter's five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
⏩ In-depth analysis, as well as the market size and segmentation, help you identify current Glucagon Market opportunities.
⏩ The largest countries in each region are mapped according to their revenue contribution to the market.
⏩ The Glucagon Market research report gives a thorough analysis of the current status of the Glucagon Market's major players.
Key questions answered in the report:
➧ What will the market development pace of the Glucagon Market?
➧ What are the key factors driving the Glucagon Market?
➧ Who are the key manufacturers in the market space?
➧ What are the market openings, market hazards,s and market outline of the Glucagon Market?
➧ What are the sales, revenue, and price analysis of the top manufacturers of the Glucagon Market?
➧ Who are the distributors, traders, and dealers of Glucagon Market?
➧ What are the market opportunities and threats faced by the vendors in the Glucagon Market?
➧ What are deals, income, and value examination by types and utilizations of the Glucagon Market?
➧ What are deals, income, and value examination by areas of enterprises in the Glucagon Market?
Purchase Now Up to 25% Discount on This Premium Report: https://www.omrglobal.com/buy-now/glucagon-market?license_type=license-single-user
Reasons To Buy The Glucagon Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods
Contact Us:
Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Website: www.omrglobal.com
Follow Us: LinkedIn | Twitter
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glucagon Market Set to Witness Significant Growth by 2032 | Eli Lilly and Company, Novo Nordisk, Amphastar Pharmaceuticals, Xeris Pharmaceuticals here
News-ID: 3965465 • Views: …
More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…

Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…

Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…

5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for Glucagon
Escalating Diabetes Prevalence Drives The Global Glucagon-Like Peptide 1 Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Glucagon-like Peptide 1 Market Size By 2025?
The market size for glucagon-like peptide 1 has experienced robust growth in the past few years. It is projected to increase from $20.88 billion in 2024 to $22.37 billion in 2025, with a compound annual growth rate (CAGR)…
Glucagon Injection Market Size And Global Industry Forecast 2034
On May 12 , 2025, Exactitude Consultancy., Ltd. released a research report titled "Glucagon Injection Market". This report covers the global Glucagon Injection market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along…
Top Factor Driving Glucagon-like Peptide 1 Market Growth in 2025: Escalating Dia …
"How Are the key drivers contributing to the expansion of the glucagon-like peptide 1 market?
The global glucagon-like peptide 1 market is predicted to be bolstered by the increasing occurrence of diabetes. Diabetes characterizes a condition where there is an excess of blood sugar or blood glucose. The medical treatment of conditions such as type 2 diabetes, which could result in weight loss and better control of blood sugar, uses glucagon-like…
Top Factor Driving Glucagon-like Peptide 1 Market Growth in 2025: Escalating Dia …
How Are the key drivers contributing to the expansion of the glucagon-like peptide 1 market?
The global glucagon-like peptide 1 market is predicted to be bolstered by the increasing occurrence of diabetes. Diabetes characterizes a condition where there is an excess of blood sugar or blood glucose. The medical treatment of conditions such as type 2 diabetes, which could result in weight loss and better control of blood sugar, uses glucagon-like…
Glucagon Market Trends, Segmentation, Growth, Analysis and Forecast 2023-2029
The global glucagon market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period. Glucagon is a metabolic hormone that increases the glucose level in the blood with the support of the liver which rapidly converts glycogen into glucose. The glucagon is secreted by the pancreas, which is further converted into glucose and released in the blood. It is basically used in the treatment of disorders…
Glucagon Market Trends, Research Report, Growth, Opportunities and Forecast 2023 …
The global glucagon market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period. Glucagon is a metabolic hormone that increases the glucose level in the blood with the support of the liver which rapidly converts glycogen into glucose. The glucagon is secreted by the pancreas, which is further converted into glucose and released in the blood. It is basically used in the treatment of disorders…